Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study
- on behalf of the ELECT Study Group
Producción científica: Article › revisión exhaustiva
22
El enlace se abre en una pestaña nueva
Citas
(Scopus)